Page 73 - Application Handbook - Liquid Chromatography
P. 73

Application  No.L500
    News

            Identical to the analysis with TFA derivatization,   The example analysis of Kakkonto is shown in Fig. 8,
            aflatoxin standard solution was added to the complex   and the analytical conditions are shown in Table  2.
            crude drug Kakkonto and analysis performed. The    Although an impurity peak was eluted between
            pretreatment procedure is shown in Fig.  7. An     aflatoxin G1 and B2 despite use of the immunoaffinity
            AFLAKING immunoaffinity column (Horiba, Ltd.) was   column, the impurity peak was fully separate from the
            also used in a cartridge to remove impurities. The   two aflatoxin peaks, and the analysis time was
            pretreatment procedure up to this purification step is   completed in 12 minutes even after adding a cleaning
            identical to that shown in Fig. 2. Aflatoxin standard   process.
            solution was added to the crude drug sample so each
            aflatoxin was present at a concentration of 0.25 µg/kg
            (total 1 µg/kg). This is equivalent to 1/10th the reference
            concentration stipulated in the proposed revision to the
            Japanese Pharmacopoeia 17th Edition.


                                                                    uV
                                                                 3250
                 Sample 1.0 g                                    3000  ■Peaks
                                                                 2750  1. Aflatoxin G2
                      (Aflatoxin standard solution)              2500  2. Aflatoxin G1
                                                                 2250  3. Aflatoxin B2
                      4 mL  acetonitrile/water/methanol = 6/4/1 (v/v/v)                         3
                                                                 2000  4. Aflatoxin B1  1
                                                                 1750
                 Shake for 30 min                                1500
                                                                 1250
                                                                 1000
                 Centrifuge                                      750                      2           4
                                                                 500
                                                                 250
                 (2 mL) : up to 50 mL with                         0
                 4 % polysorbate 20 in phosphate buffered saline  -250
                                                                   0.0  0.5  1.0  1.5  2.0  2.5  3.0  3.5  4.0  4.5  5.0  5.5  min
                 (50 mL)
                                                               Fig. 8  Chromatogram of Kakkonto by Direct Detection—UHPLC
                                                                    Analysis
                                                                    (Upper: With Standard Solution, Lower: Without
                 Clean-up with immunoaffinity column “AFLAKING”     Standard Solution)

                  Elution by acetonitrile (3 mL)




                 Evaporation by N2 gas

                      0.5 mL
                      water/acetonitrile = 9/1 (v/v)



                 UHPLC



                        Fig. 7  Pretreatment Procedure



            Note: Aflatoxins are degraded by UV light and while in solution will
                adsorb to glass surfaces. The vials used in analyses were pre-
                cleaned, low-adsorption brown glass vials.
            *1)  "Handling of Foods Containing Aflatoxins" (Japanese Ministry of
               Health, Labour and Welfare, Dept. of Food Safety Notification
               0331 No. 5, March 31, 2011)
            *2)  "Test Method for Total Aflatoxins" (Japanese Ministry of Health,
               Labour and Welfare, Dept. of Food Safety Notification 0816 No. 2,
               August 16, 2011)


                                                                                                      First Edition: Jan. 2016


                                               For Research Use Only. Not for use in diagnostic procedures.
                                               The content of this publication shall not be reproduced, altered or sold for any commercial purpose without the written approval of Shimadzu.
                                               The information contained herein is provided to you "as is" without warranty of any kind including without limitation warranties as to its
                                               accuracy or completeness. Shimadzu does not assume any responsibility or liability for any damage, whether direct or indirect, relating to the
                                               use of this publication. This publication is based upon the information available to Shimadzu on or before the date of publication, and subject
                                               to change without notice.
       www.shimadzu.com/an/                                                                        © Shimadzu Corporation, 2016
   68   69   70   71   72   73   74   75   76   77   78